Coricidin HBP abuse: Patient characteristics and psychiatric manifestations as recorded in an inpatient psychiatric unit

Journal of Addictive Diseases

Volumn 27, Issue 1, 2008, Pages 25-32

  Dickerson, Daniel L ^a   Schaepper, Mary Ann ^b   Peterson, Mark D ^c   Ashworth, Michelle D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^c PATTON STATE HOSPITAL   (United States)

Author keywords

Adolescents; Coricidin; Depression; Dextromethorphan; Teenagers

Indexed keywords

CORICIDIN; CORICIDIN HBP; DEXTROMETHORPHAN; UNCLASSIFIED DRUG; CHLORPHENIRAMINE; CORICIDINHBP; PARACETAMOL; PHENYLPROPANOLAMINE;

ADOLESCENT; AGGRESSION; AGITATION; ALCOHOL ABUSE; ARTICLE; ATTENTION DISTURBANCE; AUDITORY HALLUCINATION; BEHAVIOR DISORDER; BIPOLAR DISORDER; BLUNTED AFFECT; CARDIOTOXICITY; CAUCASIAN; CHILD; CHILD PSYCHIATRY; CLINICAL ARTICLE; DEPRESSION; DISORIENTATION; DRUG ABUSE; DRUG OVERDOSE; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; PSYCHIATRIC DEPARTMENT; PSYCHOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SLURRED SPEECH; SUICIDAL IDEATION; SUICIDE ATTEMPT; SYMPTOMATOLOGY; VISUAL HALLUCINATION; ADDICTION; AGE; ALCOHOLISM; CHEMICALLY INDUCED DISORDER; COMORBIDITY; CROSS-SECTIONAL STUDY; DOSE RESPONSE; DRUG COMBINATION; HEART BLOCK; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; INTOXICATION; PSYCHOLOGICAL ASPECT; SEX DIFFERENCE; STATISTICS; UNITED STATES;

ACETAMINOPHEN; ADOLESCENT; AGE FACTORS; ALCOHOLISM; CALIFORNIA; CHILD; CHLORPHENIRAMINE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; HEART BLOCK; HOSPITALIZATION; HUMANS; MALE; MENTAL DISORDERS; OVERDOSE; PHENYLPROPANOLAMINE; PSYCHIATRIC DEPARTMENT, HOSPITAL; PSYCHOSES, SUBSTANCE-INDUCED; RETROSPECTIVE STUDIES; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; SUICIDE, ATTEMPTED; TACHYCARDIA, VENTRICULAR;

EID: 46449131795     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v27n01_03     Document Type: Article

References (13)

1. Ford M. Clinical Toxicology. Philadelphia: W.B. Sauders Company, 2001: 635.
2. National Drug Intelligence Center. Intelligence Bulletin: DXM (Dextromethorphan). Available at http:// www.usdoj.gov/ndic/pubs11/11563/11563t. htm#Table1. Accessed January 23, 2006.
3. Banerji S, Anderson IB. Abuse of Coricidin HBP Cough & Cold Tablets: episodes recorded by a poison control center. Am. Health-Syst-Pharm. 2001; 58:1811-1814.
4. Kirages T, Sule H, Mycyk M. Severe manifestations of Coricidin intoxication. Am J Emerg Med. 2003; 21:473-475: doi:10.1016/S0735-6757(03)00168- 2
5. Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL. Harrison's Principles of Internal Medicine, 14th ed. New York: McGraw-Hill, 1998: 2531.
6. Bruns J. Toxicity, Anticholinergic. Available at http://www.emedicine. com/emerg/topic36.htm. Accessed August, 19, 2006.
7. Green G. NCAA study of substance abuse and abuse habits of college student-athletes. Clin J Sport Med. 2001;11(1):51-56.
8. Rickert VI. Prevalence and risk factors for LSD use among young women. J Pediatr Adolesc Gynecol. 2003;16(2):67-75: doi:10.1016/S1083-3188(03)00012-3
9. Salsali M. Analysis of dextrophan, a metabolite of dextromethorphan, using as chromotography with electron-capture detection. J Pharmacol Toxicol Methods. 1999; 41(4):143-146: doi:10.1016/S1056-8719(99) 00033-7
10. Zawertailo L, Kaplan H, Busto U, Tyndale R, Sellers E. Psychotropic effects of dextromethorphan are altered by CYP-2D5 polymorphism: a pilot study. J Clin Psychopharmacol. 1998;18(4):332-337.
11. Schier J, Diaz J. Avoid unfavorable consequences: dextromethorphan can bring about a false positive phencyclidine urine drug screen. Journal of Emergency Medicine 2000;18:379-381: doi:10.1016/S0736-4679(99) 00234-6
12. Rogowski R, Krenzelok E. Averting the medical, social, and legal implications of a false positive phencyclidine determination (Abstract #167-NACCT Annual Meeting). Clin Toxicol. 1997;55: 331.
13. StorrowA. The dextromethorphan defense: dextromethorphan and the opioid screen. Acad Emerg Med. 1995; 2(9):791-794.